4-苯甲氧基吲哚-3-甲醛 | 7042-71-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 4-苯甲氧基吲哚-3-甲醛
• 中文别名: 4-苄氧基吲哚-3-甲醛；4-苄氧基-3-吲哚甲醛
• 英文名称: 4-benzyloxyindole-3-carbaldehyde
• 英文别名: 4-(benzyloxy)-1H-indole-3-carbaldehyde；4-benzyloxyindole-3-carboxaldehyde；4-phenylmethoxy-1H-indole-3-carbaldehyde
• CAS: 7042-71-9
• 化学式: C₁₆H₁₃NO₂
• mdl: MFCD00152002
• 分子量: 251.285
• InChiKey: WURDDLFAUSUSLT-UHFFFAOYSA-N

物化性质

• 熔点：
  167°C (dec.)
• 沸点：
  474.2±30.0 °C(Predicted)
• 密度：
  1.267±0.06 g/cm3(Predicted)
• 溶解度：
  4.6 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.062
• 拓扑面积：
  42.1
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2933990090
• 安全说明：
  S22,S24/25
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Benzyloxyindole-3-carboxaldehyde
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Benzyloxyindole-3-carboxaldehyde
CAS number: 7042-71-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C16H13NO2
Molecular weight: 251.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-苯甲氧基吲哚-3-甲醛 在 lithium aluminium tetrahydride 、 ammonium acetate 作用下， 以 四氢呋喃 为溶剂， 反应 3.25h， 生成 2-(4-(benzyloxy)-1H-indol-3-yl)ethanamine
  参考文献：
  名称：

  TRYPTAMINE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

  摘要：

  The present disclosure relates to tryptamine compounds, and pharmaceutically acceptable salts, stereoisomers, tautomers, solvates, polymorphs, or prodrugs thereof, to pharmaceutical compositions, and in some embodiments, to serotonin 5-HT2receptor agonists and uses in the treatment of diseases such as those diseases associated with a 5-HT2receptor.

  公开号：

  WO2024046837A1
• 作为产物：
  描述：

  4-碘吲哚-3-甲醛 、 苯甲醇 在 copper(l) iodide 、 potassium hydride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 以70%的产率得到4-苯甲氧基吲哚-3-甲醛
  参考文献：
  名称：

  Yamada, Fumio; Tamura, Mayumi; Somei, Masanori, Heterocycles, 1998, vol. 49, # 1, p. 451 - 457

  摘要：

  DOI：

文献信息

• Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1<i>H</i>-Indol-3-yl)-1<i>H</i>-imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin
  作者：Qinghui Wang、Kinsie E. Arnst、Yuxi Wang、Gyanendra Kumar、Dejian Ma、Stephen W. White、Duane D. Miller、Weimin Li、Wei Li

  DOI：10.1021/acs.jmedchem.9b00706

  日期：2019.7.25

  10ab and 10bb in complex with tubulin confirmed their improved molecular interactions to the colchicine site. In vitro, biological studies showed that new ABI-231 analogues disrupt tubulin polymerization, promote microtubule fragmentation, and inhibit cancer cell migration. In vivo, analogue 10bb not only significantly inhibits primary tumor growth and decreases tumor metastasis in melanoma xenograft

  ABI-231是一种有效的，口服生物利用的微管蛋白抑制剂，可与秋水仙碱结合位点相互作用，目前正在接受前列腺癌的临床试验。在与微管蛋白复合的ABI-231晶体结构的指导下，我们围绕3-吲哚部分进行了结构-活性关系研究，从而发现了几种有效的ABI-231类似物，最著名的是10ab和10bb。与微管蛋白复合的10ab和10bb的晶体结构证实了它们与秋水仙碱位点的分子相互作用得到了改善。在体外，生物学研究表明，新的ABI-231类似物可破坏微管蛋白聚合，促进微管碎裂并抑制癌细胞迁移。体内，类似物10bb不仅在黑素瘤异种移植模型中显着抑制原发性肿瘤生长并减少肿瘤转移，而且在抗紫杉烷的PC-3 / TxR模型中显示出显着的克服紫杉醇抗性的能力。此外，药理学筛选表明10bb潜在脱靶功能的风险较低。
• Synthetic Studies of Psilocin Analogs Having Either a Formyl Group or Bromine Atom at the 5- or 7-Position.
  作者：Fumio Yamada、Mayumi Tamura、Atsuko Hasegawa、Masanori Somei

  DOI：10.1248/cpb.50.92

  日期：——

  Psilocin analogs having either a formyl group (9—12) or a bromine atom (13—18) at the 5- or 7-position have been prepared for the first time. Syntheses of 5- and 7-bromo derivatives of 4-hydroxy- (23, 24, 28) and 4-benzyloxyindole-3-carbaldehyde (19, 25, 29, 30), 4-benzyloxyindole-3-acetonitriles (20, 31), and 4-benzyloxy-N, N-dimethyltryptamine (32, 34, 35) have also been established.

  首次合成了在5位或7位具有甲酰基（9—12）或溴原子（13—18）的Psilocin类似物。此外，还建立了4-羟基（23, 24, 28）和4-苄氧吲哚-3-甲醛（19, 25, 29, 30）、4-苄氧吲哚-3-乙腈（20, 31）以及4-苄氧-N,N-二甲基色氨酸（32, 34, 35）的5-和7-溴衍生物的合成方法。
• Substituted naphthylene compounds exhibiting selective leukotriene
  申请人：Rhone-Poulenc Rorer Pharmaceuticals Inc.

  公开号：US05468898A1

  公开（公告）日：1995-11-21

  This invention relates to bicyclic aryl compounds having selective LTB.sub.4 antagonist properties and comprising an amido substituent, a substituent group having a terminal carboxylic acid or derivative thereof and a lipophilic substituent, and to methods for the treatment of disorders which result from LTB.sub.4 activity and pharmaceutical compositions including such compounds.

  这项发明涉及具有选择性LTB.sub.4拮抗性的双环芳基化合物，包括一个酰胺取代基、一个具有终端羧酸或其衍生物的取代基团和一个亲脂性取代基，并涉及用于治疗由LTB.sub.4活性引起的疾病的方法以及包括这些化合物的药物组合物。
• [EN] ANABASEINE DERIVATIVES USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES<br/>[FR] DERIVES D'ANABASEINE UTILES POUR LE TRAITEMENT DE MALADIES NEURODEGENERATIVES
  申请人：MEMORY PHARM CORP

  公开号：WO2004019943A1

  公开（公告）日：2004-03-11

  The compounds of the present invention are of formula (I): wherein A, R3, R4 is as defined herein, are useful as ligands for nicotinic receptors.

  本发明的化合物的化学式为（I）：其中A、R3、R4如本文所定义，可用作尼古丁受体的配体。
• Development of Novel Mitochondrial Pyruvate Carrier Inhibitors to Treat Hair Loss
  作者：Xiaoguang Liu、Aimee A. Flores、Lisa Situ、Wen Gu、Hui Ding、Heather R. Christofk、William E. Lowry、Michael E. Jung

  DOI：10.1021/acs.jmedchem.0c01570

  日期：2021.2.25

  Herein, we report the synthesis and evaluation of novel analogues of UK-5099 both in vitro and in vivo for the development of mitochondrial pyruvate carrier (MPC) inhibitors to treat hair loss. A comprehensive understanding of the structure–activity relationship was obtained by varying four positions of the hit compound, namely, the alkyl group on the N1 position, substituents on the indole core, various

  在此，我们报告了 UK-5099 新型类似物的体外和体内合成和评估，用于开发治疗脱发的线粒体丙酮酸载体 (MPC) 抑制剂。通过改变命中化合物的四个位置，即N1位上的烷基、吲哚核心上的取代基、各种芳香族和杂芳香族核心结构以及各种迈克尔受体，获得了对构效关系的全面了解。主要发现是，N1 位带有 3,5-双（三氟甲基）苄基的抑制剂在增加细胞乳酸产量方面比JXL001 (UK-5099) 具有更好的活性。此外，具有7-氮杂吲哚杂环的类似物JXL069也被证明具有显着的MPC抑制活性，这进一步增加了药物设计的化学空间。最后，超过10种类似物在剃毛小鼠身上进行了局部治疗试验，并促进了小鼠明显的毛发生长。